The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(5-((2-(benzo[d]thiazol-2-yl)hydrazono)methyl)furan-2-yl)-2-methylbenzoic acid ID: ALA2398290
Max Phase: Preclinical
Molecular Formula: C20H15N3O3S
Molecular Weight: 377.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(C(=O)O)cccc1-c1ccc(/C=N/Nc2nc3ccccc3s2)o1
Standard InChI: InChI=1S/C20H15N3O3S/c1-12-14(5-4-6-15(12)19(24)25)17-10-9-13(26-17)11-21-23-20-22-16-7-2-3-8-18(16)27-20/h2-11H,1H3,(H,22,23)(H,24,25)/b21-11+
Standard InChI Key: WRYUQDYTDHZOQS-SRZZPIQSSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-7.1181 -10.9536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.1169 -11.7732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4134 -12.1821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4117 -10.5448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.7005 -10.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6971 -11.7732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9131 -12.0230 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-4.4356 -11.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9218 -10.6911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6184 -11.3494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2139 -10.6392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.3967 -10.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9921 -9.9243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1830 -9.8318 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0180 -9.0314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7276 -8.6270 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3289 -9.1775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2736 -8.6944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3929 -9.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1369 -8.8364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2180 -8.0224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5491 -7.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1957 -7.8844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8006 -9.3132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7196 -10.1263 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5453 -8.9767 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3114 -9.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 2 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
15 18 1 0
20 24 1 0
24 25 2 0
24 26 1 0
19 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 377.43Molecular Weight (Monoisotopic): 377.0834AlogP: 5.01#Rotatable Bonds: 5Polar Surface Area: 87.72Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.96CX Basic pKa: 3.22CX LogP: 4.95CX LogD: 2.17Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: -1.82
References 1. Sleebs BE, Kersten WJ, Kulasegaram S, Nikolakopoulos G, Hatzis E, Moss RM, Parisot JP, Yang H, Czabotar PE, Fairlie WD, Lee EF, Adams JM, Chen L, van Delft MF, Lowes KN, Wei A, Huang DC, Colman PM, Street IP, Baell JB, Watson K, Lessene G.. (2013) Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL., 56 (13): [PMID:23767404 ] [10.1021/jm400556w ] 2. Hennessy EJ.. (2016) Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity., 26 (9): [PMID:26988306 ] [10.1016/j.bmcl.2016.03.032 ]